Awad Ahmed J, Walcott Brian P, Stapleton Christopher J, Ding Dale, Leed Cheng-Chia, Loeffler Jay S
Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
Department of Neurological Surgery, Massachusetts General Hospital, White Building Room 502, 55 Fruit Street, Boston, MA 02114, USA.
J Clin Neurosci. 2015 Jun;22(6):945-950. doi: 10.1016/j.jocn.2015.01.015. Epub 2015 Apr 23.
We perform a systematic review of repeat radiosurgery for cerebral arteriovenous malformations (AVM) with an emphasis on lesion obliteration rates and complications. Radiosurgery is an accepted treatment modality for AVM located in eloquent cortex or deep brain structures. For residual or persistent lesions, repeat radiosurgery can be considered if sufficient time has passed to allow for a full appreciation of treatment effects, usually at least 3years. A systematic review was performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. References for this review were identified by searches of MEDLINE, Web of Science and Google Scholar databases. A total of 14 studies comprising 733 patients met the review criteria and were included. For series that reported target dose at both first and repeat treatments, the weighted means were 19.42Gy and 19.06Gy, respectively. The mean and median obliteration rate for the repeat radiosurgery treatments were 61% (95% confidence interval 51.9-71.7%) and 61.5%, respectively. The median follow up following radiosurgery ranged from 19.5 to 80months. Time to complete obliteration after the repeat treatment ranged from 21 to 40.8months. The most common complications of repeat radiosurgery for AVM included hemorrhage (7.6%) and radiation-induced changes (7.4%). Repeat radiosurgery can be used to treat incompletely obliterated AVM with an obliteration rate of 61%. Complications are related to treatment effect latency (hemorrhage risk) as well as radiation-induced changes. Repeat radiosurgery can be performed at 3 years following the initial treatment, allowing for full realization of effects from the initial treatment prior to commencing therapy.
我们对脑动静脉畸形(AVM)的重复放射外科治疗进行了系统评价,重点关注病变闭塞率和并发症。放射外科是治疗位于功能区皮层或深部脑结构的AVM的一种公认治疗方式。对于残留或持续存在的病变,如果已过去足够时间以充分评估治疗效果,通常至少3年,则可考虑重复放射外科治疗。按照系统评价和Meta分析的首选报告项目(PRISMA)指南进行了系统评价。通过检索MEDLINE、科学网和谷歌学术数据库确定了本评价的参考文献。共有14项研究(733例患者)符合评价标准并被纳入。对于在首次和重复治疗时均报告了靶剂量的系列研究,加权平均值分别为19.42Gy和19.06Gy。重复放射外科治疗的平均闭塞率和中位数闭塞率分别为61%(95%置信区间51.9 - 71.7%)和61.5%。放射外科治疗后的中位随访时间为19.5至80个月。重复治疗后完全闭塞的时间为21至40.8个月。AVM重复放射外科治疗最常见的并发症包括出血(7.6%)和放射性改变(7.4%)。重复放射外科可用于治疗未完全闭塞的AVM,闭塞率为61%。并发症与治疗效果潜伏期(出血风险)以及放射性改变有关。重复放射外科可在初始治疗3年后进行,以便在开始治疗前充分实现初始治疗的效果。